Additional Phase 3 readouts across the TRIUMPH and TRANSCEND-T2D programs are expected through 2026 and 2027
Increased gastrointestinal side effects: Both semaglutide and berberine are known for causing gastrointestinal side effects, including nausea, diarrhea , constipation, and abdominal discomfort
Binders loosely hold mycotoxins and in some patients binders will cause a flare of symptoms by mobilizing mycotoxins faster than the patient can eliminate them
The GLP-1 Support Patch Pack is crafted to help you achieve long-term success with your GLP-1 therapy by minimizing common side effects that can disrupt your progress
Heres why were doing it this way
Unlike shorter-acting GLP-1 agonists, semaglutide can be injected at any time of day, with or without food, maintaining therapeutic plasma concentrations throughout the week